|
|
|
|
|
|
|
|
Preventing Mothers' Deaths in Childbirth
|
|
Summary
A low cost, off-patent drug stops postpartum hemorrhage. Thousands of women's lives can be saved by making it available to traditional midwives through market distribution in developing countries.
 read updates from the field
|
Received $27,477 from 76 donations from people like:
|
More Information About this Project
Project Needs and Beneficiaries
Each year, twice as many women die in childbirth as people who died in the 2004 tsunami. 99% of these deaths are in developing countries and hemorrhage is the most common cause worldwide. Bleeding can be controlled in a clinic, but our projects are the first to show traditional midwives can save lives in a woman’s home, where most births take place. This is also where most maternal deaths occur in the developing world--well beyond the reach of hospitals and government health services.
Activities
We sponsor clinical demonstration studies with traditional midwives; co-sponsor government policy meetings; train doctors and midwives to use misoprostol; and develop market distribution for the drug to be available in pharmacies & clinics countrwide
Funding Information
Total Funding Received to Date: $27,477
Remaining Goal to be Funded: $22,523
Total Funding Goal: $50,000
Additional Documentation
This project has provided additional documentation in a Microsoft Word file (projdoc.doc).
Resources
Why this Project is Important
Potential Long Term Impact
The project is uniquely scalable and sustainable. With this drug, traditional midwives get their first effective technology and see the first large-scale decline in mortality. Low-cost distribution will ensure widespread access.
Project Message
“My eldest daughter died of postpartum hemorrhage four years ago. In this project we are saving women’s lives with misoprostol. If we had had this earlier, we would have saved her life too.”
- Margaum, traditional midwife in our Tanzanian study
When this Project was Updated
Last Updated
This project was last updated on August 15, 2007.
Date Added to GlobalGiving
This project was added to the GlobalGiving project catalog on January 17, 2005.
Latest Update from the Field
Nigerians Approve New Misoprostol Clinical Guidelines
By Amy Grossman - Communications Manager, August 15, 2007 10:24 PM
Following our active involvement in achieving the world's first regulatory approval of misoprostol for postpartum hemorrhage, Venture Strategies for Health and Development assisted in the preparation of the misoprostol clinical guidelines for physicians and nurses in Nigeria. These guidelines were recently approved by the Nigerian Family Ministry of Health after they convened a technical expert meeting.
The inclusion of misoprostol in the country's official clinical guidelines is a fundamental step towards ensuring that misoprostol is used at the facility level to control postpartum hemorrhage - excessive bleeding after childbirth.
Dissemination and sensitization on the newly approved clinical guidelines have begun for health care professionals throughout the country. These sensitization efforts are coinciding with ongoing training efforts to familiarize health care providers with Active Management of Third Stage Labor and the Judicious use of Misoprostol and distribution activities of the local distributor, Emzor.
Links:
Read 3 more "Updates from the Field" |
Comment on this update
 Subscribe to "Updates from the Field" by E-Mail
How Else You Can Help
Spread the Word on your Profile, Blog, or Website
Put a widget for this project on your profile, blog or website to turn your friends into givers. Using our widget, it's quick and easy to add this widget to your profile or blog!
|
|
|
|
|
|
|
giving cart
create an account
login
my profile
logout
Nigeria
Health
Printer Friendly
Add to Favorite Projects
Add to Registry
Subscribe to RSS Feed
Spread the Word
Tag on del.icio.us
Add to Facebook
Digg It!
Add to Google Bookmarks
Add to Yahoo! Bookmarks
Reddit